| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |